Emilia Javorsky
speaker
1,653 appearances
2 recordings
1 series
first heard Mar 2026
last heard 20 Mar
Emilia Javorsky’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 2 in all, peaking in Mar 2026 with 2.
Appearances
Derek Thompson captures this sentiment in his essay on American progress, observing that if there were a Nobel Prize for deploying and adopting technology at scale, our legacy wouldn't be so sterling.
In biology, where discovery launches rather than concludes a story, this deployment challenge is exponentially more severe.
Even if a potential cure were discovered in a laboratory today, there is no guarantee we would recognize it as such.
nor that it would successfully navigate translational research, regulatory approval, manufacturing scale-up, reimbursement negotiations, and clinical adoption to reach patients who need it.
Like we saw earlier in the case of tenespamycin, even drugs who successfully navigated most of the Odyssean voyage can be shelved steps from Ithaca.
We likely already possess undiscovered life-extending therapies, but they're stuck behind roadblocks and knowledge gaps in our broken system.
Staking hope on new technologies as Rosetta Stone's.
overhyped promises of transformative new technology unlocking therapeutic revolutions predate big tech's arrival and the current fanfare around superintelligence.
When President Clinton announced the completion of the Human Genome Project in 2000, he proclaimed that, "...humankind is on the verge of gaining immense new power to heal."
and that the technology will revolutionize the diagnosis, prevention, and treatment of most, if not all, human diseases.
The statement could have been written by an AI CEO today.
Yet, it wasn't about AI, but genomics.
The project's lead, Francis Collins, speculated that perhaps in another 15 or 20 years, you will see a complete transformation in therapeutic medicine.
The assumption was straightforward.
Mapping the human genome would provide a Rosetta Stone between disease cause and cure.
If we knew each person's fundamental code, we could simply identify and debug the errors causing disease.
It was software thinking applied to biology.
Find the bug, fix the code, ship the cure.
Twenty-five years later, we confront the reality that this assumption was profoundly naive.
Nearly all diseases proved vastly more complex than single bugs in source code.
Showing 961–980 of 1,653 · page 49 of 83
← Previous
Next →